Viewing Study NCT04477993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:13 AM
Ignite Modification Date: 2025-12-25 @ 11:23 PM
Study NCT ID: NCT04477993
Status: TERMINATED
Last Update Posted: 2021-04-08
First Post: 2020-07-13
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
Sponsor: Vanderson Geraldo Rocha
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Acute Respiratory Syndrome Coronavirus 2 View
None SARS-CoV2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SARS-CoV2 View
None Severe Acute Respiratory Syndrome Coronavirus 2 View
None Janus Kinase Inhibitors View
None Safety View
None Clinical Efficacy View
None Clinical Trial View